Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer

BACKGROUND: Immunotherapy is significantly revolutionizing cancer treatment and demonstrating promising efficacy in gastric cancer (GC) patients. However, only a subset of patients could derive benefits from targeted monoclonal antibody therapy against programmed death receptor 1 (PD-1). This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yidan, Li, Xiaoli, Yang, Yudan, Shi, Hao, Wang, Shaofang, Gao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643875/
https://www.ncbi.nlm.nih.gov/pubmed/38022654
http://dx.doi.org/10.3389/fimmu.2023.1274431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643875/
https://www.ncbi.nlm.nih.gov/pubmed/38022654
http://dx.doi.org/10.3389/fimmu.2023.1274431

Ejemplares similares